Recent Tech Transfer Deals (06/2010)
This article was originally published in Start Up
Executive Summary
Our monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.You may also be interested in...
Keeping Track: Quick Trips From Breakthrough Designation To Market
Phase III data earns a breakthrough therapy designation for Resverlogix’ apabetalone; previous companies to follow that strategy swiftly advance to NDA submission, as seen with Novartis’ capmatinib and Seattle Genetics’ tucatinib.
Breakthrough Therapy Designations: Phase II Data Is Sweet Spot For US FDA Award
Pink Sheet analysis finds that evidence from early-stage trials supports most BTD requests, but about three in 10 designations are granted on the basis of pivotal-stage data.
Medicare-For-Hmmm: A Year Of House Hearings Show Democratic Disunity
Four House hearings show how far away even many Democrats are from supporting a single payer system in the US.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports